This report offers an overview of the advances in neuroscience research.

Table Of Contents

Table of Contents
1. Executive Summary
Scope and Methodology

* Scope
* Methodology

Summary of Key Trends and Developments

* Key Research Developments
* Key Trends in Neuroscience Research

2. Technology Assessment of Neuroscience Research
Technology Primer on Neuroscience Research

* Neurological Disorders--Technology Primer
* Current Modalities in Diagnosis and Treatment of Neurological Disease

Trend Assessment of Neurological Research

* Key Drivers in Neurological Research
* Key Challenges in Neurological Research

3. Strategic Assessment of Advances in Neurological Research - Analyst Insights
Industry Analysis of Neurological Research

* Assessing the External Environment for Neurological Research - Porter' s 5 Forces
* PEST Analysis for Development of Therapies for Neurological Diseases
* Environmental Impact on the Growth of Neurosciences--Porter' s Diamond Analysis
* Competency Analysis for Neurosciences

Technology Assessment and Trend Evaluation for Opportunities in Neurosciences

* Stakeholder Analysis for Neuroscience Research and Therapeutics
* Scenario Analysis for Neurological Research
* Current Trends in Neurosciences

Strategic Assessment of Trends and Recommendations

* The Directionality of Neuroscience Research: Future Trends through the Strebel Model
* Recommendations on Strategies for Growth in Neurosciences: TAC Matrix and the DS MODEL

4. Noteworthy Developments in Neurological Research
Industry Developments in Neurological Research

* Molecular Imaging Agents for Alzheimer' s and Parkinson' s Disease
* MPAC for Neurological Diseases
* Gene Therapy for Neurodegenerative Disorders
* Neuroprotective Therapeutics for a Wide Array of Neurodegenerative Disorders
* Cell Replacement Therapy for Parkinson' s Disease
* A Potential Therapeutic for Huntington' s Disease
* Innovative Small Molecules for Psychiatry and Neurology
* Noninvasive Diagnostic Tool for Alzheimer' s Detection
* A Natural Protein-Based Drug for Parkinson' s Disease
* Diagnostics and Therapeutics for Parkinson' s Disease
* Advanced Therapeutics for Neurological Disorders
* Nondopaminergic Molecule for Parkinson' s Disease Symptoms

Academic Developments in Neurological Research

* Alzheimer' s Marker in Cognitively Sound Elderly
* Small Molecule Neuroprotective Agents for Parkinson' s Disease
* New Class of Drugs for Alzheimer' s Disease Management
* Diffusion Tensor Imaging--A Promising Method for PD Diagnosis
* Novel Molecule for Epilepsy Management
* Novel Compound for Huntington' s Disease

5. Patents and Key Participants
World Patents

* Industry Patents
* Academia Patents

Key Participants

* Industry Participants
* Academic Participants

6. Decision Support Database
Decision Support Database Tables

* Percentage Pharmaceutical RandD Expenditure--World (2002 to 2012)
* Pharmaceutical RandD Expenditure--World (2002 to 2012)
* Total Healthcare Expenditure--World (2004 to 2014)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Global R&D Outsourcing Market 2014-2018.pdf

Global R&D Outsourcing Market 2014-2018.pdf

  • $ 2 500
  • Industry report
  • May 2014
  • by Infiniti Research Limited

About Global R&D Outsourcing Market R&D Outsourcing refers to the outsourcing of specific R&D services to third-party service providers such as designing, prototyping, testing, and manufacturing and sales. ...

Octapharma AG - Product Pipeline Review - 2014

Octapharma AG - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • April 2014
  • by Global Markets Direct

Octapharma AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Octapharma AG - Product Pipeline Review - 2014', provides an overview of the Octapharma AG's pharmaceutical research and ...

Pharmaceutical in Canada: Galderma S.A. – Product Pipeline Review – H2 2011

Pharmaceutical in Canada: Galderma S.A. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Industry report
  • April 2014
  • by Global Markets Direct

. - Product Pipeline Review - H2 2011” provides a detailed overview on the Galderma S.A.’s research and development focus. The report includes data on current developmental pipeline, complete with ...

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.